Fingerprint
Dive into the research topics of 'Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
GS-US-321-0105 and GS-US-321-0106 Investigators
Research output: Contribution to journal › Article › peer-review
101
Scopus
citations